http://www.multiwebcast.com/easl/2012/international.liver.congress.2012/19231/
http://www.echosens.com/Expertise/clinical-data.html
http://www.multiwebcast.com/easl/2012/international.liver.congress.2012/listing_poster/by_poster#_t_1026
biopsy is useless at monitoring because you cant do it many times, it is safe one every 5 years, it makes also liver damage and has a death risk althouh low and very high error rate.not used anymore in italy and almost impossible to find patients willing to do it here
fibrotest is complitely unreliable, cirrhosis has no effect on blood tests on most patients especially early
fibroscan has the highest sensibility for relevant liver damage/cirrhosis, only one that can monitor, only one to have access to the most part of the liver.it measures both fibrosis, steatosis and inflammation